晚期NSCLC维持治疗质疑与问题解析

Recently, several studies have been carried about maintenance therapy in non-small cell lung cancer, and some chemotherapy agents have been approved for clinical practice. But there are still a lot of questions about maintenance therapy that we have to consider. For example, the defects of design in...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2014
Materias:
专家述评
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000018/
https://www.ncbi.nlm.nih.gov/pubmed/24758902
http://dx.doi.org/10.3779/j.issn.1009-3419.2014.04.02
_version_ 1783331591197556736
collection PubMed
description Recently, several studies have been carried about maintenance therapy in non-small cell lung cancer, and some chemotherapy agents have been approved for clinical practice. But there are still a lot of questions about maintenance therapy that we have to consider. For example, the defects of design in maintenance therapy trials; how to choose gold standard of maintenance therapy for evaluation; who benefit from the maintenance therapy and how to estimate pharmaceutical economics. In this paper, we will make deep analysis about these issues.
format Online
Article
Text
id pubmed-6000018
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-60000182018-07-06 晚期NSCLC维持治疗质疑与问题解析 Zhongguo Fei Ai Za Zhi 专家述评 Recently, several studies have been carried about maintenance therapy in non-small cell lung cancer, and some chemotherapy agents have been approved for clinical practice. But there are still a lot of questions about maintenance therapy that we have to consider. For example, the defects of design in maintenance therapy trials; how to choose gold standard of maintenance therapy for evaluation; who benefit from the maintenance therapy and how to estimate pharmaceutical economics. In this paper, we will make deep analysis about these issues. 中国肺癌杂志编辑部 2014-04-20 /pmc/articles/PMC6000018/ /pubmed/24758902 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.04.02 Text en 版权所有©《中国肺癌杂志》编辑部2014 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 专家述评
晚期NSCLC维持治疗质疑与问题解析
title 晚期NSCLC维持治疗质疑与问题解析
title_full 晚期NSCLC维持治疗质疑与问题解析
title_fullStr 晚期NSCLC维持治疗质疑与问题解析
title_full_unstemmed 晚期NSCLC维持治疗质疑与问题解析
title_short 晚期NSCLC维持治疗质疑与问题解析
title_sort 晚期nsclc维持治疗质疑与问题解析
topic 专家述评
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000018/
https://www.ncbi.nlm.nih.gov/pubmed/24758902
http://dx.doi.org/10.3779/j.issn.1009-3419.2014.04.02
work_keys_str_mv AT wǎnqīnsclcwéichízhìliáozhìyíyǔwèntíjiěxī

Ejemplares similares